Prevalence of
antifungal
candidaemia
chromogenic agar
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
12
2018
accepted:
27
06
2019
entrez:
10
9
2019
pubmed:
10
9
2019
medline:
10
9
2019
Statut:
epublish
Résumé
Of all blood stream infections (BSI), candidaemia poses the greatest threat with a high fatality rate among children. There has been an increase in the number of reports of non- The present study aimed to demonstrate the prevalence of candidaemia among children and to characterize the involved species and their susceptibility to antifungal agents. Microbes were isolated from blood samples and identified via standard microbiological procedures. Chromogenic media was used to characterize the The data were analysed with Statistical Package for the Social Science SPSS; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows. Comparisons between the study groups were performed using the Chi square (χ Candidaemia accounted for 17.3% of all BSIs. The prevalence of candidaemia was high, the fatality rate was alarming and non-
Sections du résumé
BACKGROUND
BACKGROUND
Of all blood stream infections (BSI), candidaemia poses the greatest threat with a high fatality rate among children. There has been an increase in the number of reports of non-
AIM
OBJECTIVE
The present study aimed to demonstrate the prevalence of candidaemia among children and to characterize the involved species and their susceptibility to antifungal agents.
METHODOLOGY
METHODS
Microbes were isolated from blood samples and identified via standard microbiological procedures. Chromogenic media was used to characterize the
STATISTICAL METHODS
METHODS
The data were analysed with Statistical Package for the Social Science SPSS; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows. Comparisons between the study groups were performed using the Chi square (χ
RESULTS
RESULTS
Candidaemia accounted for 17.3% of all BSIs.
CONCLUSION
CONCLUSIONS
The prevalence of candidaemia was high, the fatality rate was alarming and non-
Identifiants
pubmed: 31496753
doi: 10.2147/IDR.S196972
pii: 196972
pmc: PMC6689130
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2409-2416Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Jpn J Infect Dis. 2005 Dec;58(6):344-8
pubmed: 16377864
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Clin Infect Dis. 2008 Apr 15;46(8):1206-13
pubmed: 18444857
J Microbiol Immunol Infect. 2009 Apr;42(2):148-53
pubmed: 19597647
J Clin Microbiol. 2010 Apr;48(4):1270-5
pubmed: 20129963
Antimicrob Agents Chemother. 2010 Aug;54(8):3149-54
pubmed: 20498325
Crit Care Clin. 2011 Jan;27(1):163-205
pubmed: 21144992
Pediatr Infect Dis J. 2011 Aug;30(8):664-8
pubmed: 21372750
Rev Soc Bras Med Trop. 2011 Oct;44(5):595-9
pubmed: 22031076
PLoS One. 2012;7(3):e33705
pubmed: 22479431
Genet Mol Biol. 2012 Jan;35(1):122-5
pubmed: 22481884
Diagn Microbiol Infect Dis. 2012 Jun;73(2):153-6
pubmed: 22494558
Diagn Microbiol Infect Dis. 2012 May;73(1):45-8
pubmed: 22578938
Ann Med Health Sci Res. 2013 Apr;3(2):238-44
pubmed: 23919197
J Infect Dev Ctries. 2014 May 14;8(5):624-34
pubmed: 24820467
J Crit Care. 2015 Aug;30(4):862.e1-5
pubmed: 26002430
Biomed Res Int. 2015;2015:256580
pubmed: 26064890
Clin Microbiol Infect. 2015 Oct;21(10):938-45
pubmed: 26093076
Clin Microbiol Infect. 2016 Jan;22(1):87-93
pubmed: 26432192
Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19:57-64
pubmed: 26465371
Curr Opin Infect Dis. 2015 Dec;28(6):514-22
pubmed: 26524326
Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):971-974
pubmed: 28213689
BMC Infect Dis. 2017 May 6;17(1):329
pubmed: 28477628